|Original language||English (US)|
|Number of pages||1|
|Journal||The Lancet Gastroenterology and Hepatology|
|State||Published - Aug 2019|
Bibliographical noteFunding Information:
The European South American Consortium to Assess Liver-Originated Neoplasia (ESCALON) project has received funding from the EU Horizon 2020 research and innovation programme under grant agreement number 825510 . It is partially funded by the Robert Wood Johnson Foundation , Harold Amos Medical Faculty Development Program, and NIH-NCI R21 CA215883-01A1 to JDD. AB reports grants from Janssen Pharma, Gilead Sciences, and Fujirebio, outside the submitted work.